nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Paclitaxel—ovarian cancer	0.223	0.297	CbGbCtD
Olmesartan—SLCO1B3—Docetaxel—ovarian cancer	0.161	0.215	CbGbCtD
Olmesartan—ABCC2—Paclitaxel—ovarian cancer	0.114	0.152	CbGbCtD
Olmesartan—ABCC2—Carboplatin—ovarian cancer	0.107	0.143	CbGbCtD
Olmesartan—ABCC2—Docetaxel—ovarian cancer	0.0823	0.11	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—ovarian cancer	0.0614	0.082	CbGbCtD
Olmesartan—Telmisartan—ABCB1—ovarian cancer	0.000417	0.43	CrCbGaD
Olmesartan—Candesartan—ABCB1—ovarian cancer	0.000336	0.347	CrCbGaD
Olmesartan—Muscle spasms—Docetaxel—ovarian cancer	0.000251	0.00101	CcSEcCtD
Olmesartan—Eosinophilia—Epirubicin—ovarian cancer	0.00025	0.001	CcSEcCtD
Olmesartan—Infection—Paclitaxel—ovarian cancer	0.00025	0.001	CcSEcCtD
Olmesartan—Pancreatitis—Epirubicin—ovarian cancer	0.000248	0.000995	CcSEcCtD
Olmesartan—Shock—Paclitaxel—ovarian cancer	0.000247	0.000993	CcSEcCtD
Olmesartan—Dizziness—Vinorelbine—ovarian cancer	0.000247	0.000992	CcSEcCtD
Olmesartan—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000247	0.000992	CcSEcCtD
Olmesartan—Nervous system disorder—Paclitaxel—ovarian cancer	0.000247	0.00099	CcSEcCtD
Olmesartan—Hypokalaemia—Doxorubicin—ovarian cancer	0.000246	0.000989	CcSEcCtD
Olmesartan—Angina pectoris—Epirubicin—ovarian cancer	0.000246	0.000988	CcSEcCtD
Olmesartan—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000246	0.000988	CcSEcCtD
Olmesartan—Tachycardia—Paclitaxel—ovarian cancer	0.000245	0.000985	CcSEcCtD
Olmesartan—Skin disorder—Paclitaxel—ovarian cancer	0.000244	0.00098	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000244	0.000978	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000244	0.000978	CcSEcCtD
Olmesartan—Bronchitis—Epirubicin—ovarian cancer	0.000243	0.000976	CcSEcCtD
Olmesartan—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000243	0.000976	CcSEcCtD
Olmesartan—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000242	0.000971	CcSEcCtD
Olmesartan—Anaemia—Docetaxel—ovarian cancer	0.000241	0.000969	CcSEcCtD
Olmesartan—Pancytopenia—Epirubicin—ovarian cancer	0.00024	0.000964	CcSEcCtD
Olmesartan—Anorexia—Paclitaxel—ovarian cancer	0.00024	0.000962	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000239	0.000958	CcSEcCtD
Olmesartan—Vomiting—Vinorelbine—ovarian cancer	0.000238	0.000954	CcSEcCtD
Olmesartan—Neutropenia—Epirubicin—ovarian cancer	0.000236	0.000949	CcSEcCtD
Olmesartan—Rash—Vinorelbine—ovarian cancer	0.000236	0.000946	CcSEcCtD
Olmesartan—Dermatitis—Vinorelbine—ovarian cancer	0.000236	0.000945	CcSEcCtD
Olmesartan—Hypotension—Paclitaxel—ovarian cancer	0.000235	0.000943	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000235	0.000943	CcSEcCtD
Olmesartan—Headache—Vinorelbine—ovarian cancer	0.000234	0.00094	CcSEcCtD
Olmesartan—Syncope—Docetaxel—ovarian cancer	0.000234	0.00094	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—ovarian cancer	0.000234	0.000939	CcSEcCtD
Olmesartan—Leukopenia—Docetaxel—ovarian cancer	0.000234	0.000938	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—ovarian cancer	0.000232	0.000929	CcSEcCtD
Olmesartan—Palpitations—Docetaxel—ovarian cancer	0.000231	0.000926	CcSEcCtD
Olmesartan—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000231	0.000926	CcSEcCtD
Olmesartan—Loss of consciousness—Docetaxel—ovarian cancer	0.00023	0.000921	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—ovarian cancer	0.000229	0.00092	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000229	0.000919	CcSEcCtD
Olmesartan—Hyperglycaemia—Epirubicin—ovarian cancer	0.000228	0.000915	CcSEcCtD
Olmesartan—Cough—Docetaxel—ovarian cancer	0.000228	0.000915	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—ovarian cancer	0.000228	0.000914	CcSEcCtD
Olmesartan—Insomnia—Paclitaxel—ovarian cancer	0.000227	0.000913	CcSEcCtD
Olmesartan—Pneumonia—Epirubicin—ovarian cancer	0.000227	0.00091	CcSEcCtD
Olmesartan—Infestation NOS—Epirubicin—ovarian cancer	0.000225	0.000905	CcSEcCtD
Olmesartan—Infestation—Epirubicin—ovarian cancer	0.000225	0.000905	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—ovarian cancer	0.000225	0.000903	CcSEcCtD
Olmesartan—AGTR1—myometrium—ovarian cancer	0.000223	0.131	CbGeAlD
Olmesartan—Chest pain—Docetaxel—ovarian cancer	0.000222	0.000892	CcSEcCtD
Olmesartan—Myalgia—Docetaxel—ovarian cancer	0.000222	0.000892	CcSEcCtD
Olmesartan—Arthralgia—Docetaxel—ovarian cancer	0.000222	0.000892	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—ovarian cancer	0.000222	0.000892	CcSEcCtD
Olmesartan—Nausea—Vinorelbine—ovarian cancer	0.000222	0.000891	CcSEcCtD
Olmesartan—Renal failure—Epirubicin—ovarian cancer	0.000222	0.000889	CcSEcCtD
Olmesartan—Dyspepsia—Paclitaxel—ovarian cancer	0.000221	0.000888	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000221	0.000886	CcSEcCtD
Olmesartan—Jaundice—Epirubicin—ovarian cancer	0.00022	0.000882	CcSEcCtD
Olmesartan—Urinary tract infection—Epirubicin—ovarian cancer	0.000219	0.000879	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—ovarian cancer	0.000219	0.000878	CcSEcCtD
Olmesartan—Decreased appetite—Paclitaxel—ovarian cancer	0.000219	0.000877	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000217	0.000872	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000217	0.000871	CcSEcCtD
Olmesartan—Fatigue—Paclitaxel—ovarian cancer	0.000217	0.00087	CcSEcCtD
Olmesartan—Losartan—ABCB1—ovarian cancer	0.000216	0.223	CrCbGaD
Olmesartan—Constipation—Paclitaxel—ovarian cancer	0.000215	0.000863	CcSEcCtD
Olmesartan—Pain—Paclitaxel—ovarian cancer	0.000215	0.000863	CcSEcCtD
Olmesartan—Haematuria—Epirubicin—ovarian cancer	0.000215	0.000863	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000214	0.000857	CcSEcCtD
Olmesartan—Anaphylactic shock—Docetaxel—ovarian cancer	0.000213	0.000855	CcSEcCtD
Olmesartan—Oedema—Docetaxel—ovarian cancer	0.000213	0.000855	CcSEcCtD
Olmesartan—Infection—Docetaxel—ovarian cancer	0.000212	0.00085	CcSEcCtD
Olmesartan—Sinusitis—Epirubicin—ovarian cancer	0.000212	0.000849	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000211	0.000847	CcSEcCtD
Olmesartan—Agranulocytosis—Epirubicin—ovarian cancer	0.00021	0.000844	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—ovarian cancer	0.00021	0.000842	CcSEcCtD
Olmesartan—Shock—Docetaxel—ovarian cancer	0.00021	0.000842	CcSEcCtD
Olmesartan—Nervous system disorder—Docetaxel—ovarian cancer	0.000209	0.000839	CcSEcCtD
Olmesartan—Thrombocytopenia—Docetaxel—ovarian cancer	0.000209	0.000838	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—ovarian cancer	0.000209	0.000837	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—ovarian cancer	0.000209	0.000837	CcSEcCtD
Olmesartan—Tachycardia—Docetaxel—ovarian cancer	0.000208	0.000835	CcSEcCtD
Olmesartan—Feeling abnormal—Paclitaxel—ovarian cancer	0.000207	0.000832	CcSEcCtD
Olmesartan—Skin disorder—Docetaxel—ovarian cancer	0.000207	0.000831	CcSEcCtD
Olmesartan—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000206	0.000825	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—ovarian cancer	0.000205	0.000823	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—ovarian cancer	0.000203	0.000816	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—ovarian cancer	0.000203	0.000815	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—ovarian cancer	0.000203	0.000814	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—ovarian cancer	0.000203	0.000814	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—ovarian cancer	0.000201	0.000806	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—ovarian cancer	0.0002	0.000802	CcSEcCtD
Olmesartan—Urticaria—Paclitaxel—ovarian cancer	0.0002	0.000802	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—ovarian cancer	0.000199	0.0008	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—ovarian cancer	0.000199	0.000799	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—ovarian cancer	0.000199	0.000798	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—ovarian cancer	0.000199	0.000798	CcSEcCtD
Olmesartan—Abdominal pain—Paclitaxel—ovarian cancer	0.000199	0.000798	CcSEcCtD
Olmesartan—Body temperature increased—Paclitaxel—ovarian cancer	0.000199	0.000798	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—ovarian cancer	0.000198	0.000796	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—ovarian cancer	0.000196	0.000785	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—ovarian cancer	0.000195	0.000781	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000194	0.000779	CcSEcCtD
Olmesartan—SLCO1B3—vagina—ovarian cancer	0.000194	0.113	CbGeAlD
Olmesartan—Insomnia—Docetaxel—ovarian cancer	0.000193	0.000774	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—ovarian cancer	0.000188	0.000753	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—ovarian cancer	0.000188	0.000753	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—ovarian cancer	0.000186	0.000746	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—ovarian cancer	0.000185	0.000744	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000185	0.000742	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—ovarian cancer	0.000184	0.00074	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000184	0.000738	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000184	0.000738	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—ovarian cancer	0.000184	0.000737	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—ovarian cancer	0.000184	0.000737	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—ovarian cancer	0.000184	0.000737	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—ovarian cancer	0.000182	0.000732	CcSEcCtD
Olmesartan—Constipation—Docetaxel—ovarian cancer	0.000182	0.000731	CcSEcCtD
Olmesartan—Pain—Docetaxel—ovarian cancer	0.000182	0.000731	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—ovarian cancer	0.000181	0.000725	CcSEcCtD
Olmesartan—Asthenia—Paclitaxel—ovarian cancer	0.00018	0.000724	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—ovarian cancer	0.000179	0.000718	CcSEcCtD
Olmesartan—Pruritus—Paclitaxel—ovarian cancer	0.000178	0.000714	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—ovarian cancer	0.000177	0.000711	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—ovarian cancer	0.000176	0.000707	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—ovarian cancer	0.000176	0.000705	CcSEcCtD
Olmesartan—AGTR1—epithelium—ovarian cancer	0.000175	0.102	CbGeAlD
Olmesartan—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000174	0.000699	CcSEcCtD
Olmesartan—AGTR1—uterine cervix—ovarian cancer	0.000174	0.102	CbGeAlD
Olmesartan—Diarrhoea—Paclitaxel—ovarian cancer	0.000172	0.00069	CcSEcCtD
Olmesartan—Back pain—Epirubicin—ovarian cancer	0.00017	0.000684	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—ovarian cancer	0.00017	0.000682	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—ovarian cancer	0.000169	0.00068	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000169	0.000677	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—ovarian cancer	0.000169	0.000676	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—ovarian cancer	0.000169	0.000676	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—ovarian cancer	0.000167	0.000671	CcSEcCtD
Olmesartan—Dizziness—Paclitaxel—ovarian cancer	0.000166	0.000667	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—ovarian cancer	0.000166	0.000666	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—ovarian cancer	0.000165	0.000664	CcSEcCtD
Olmesartan—AGTR1—decidua—ovarian cancer	0.000165	0.0968	CbGeAlD
Olmesartan—Mental disorder—Doxorubicin—ovarian cancer	0.000164	0.000658	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—ovarian cancer	0.000163	0.000656	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—ovarian cancer	0.000163	0.000654	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—ovarian cancer	0.000163	0.000653	CcSEcCtD
Olmesartan—Agitation—Epirubicin—ovarian cancer	0.000162	0.00065	CcSEcCtD
Olmesartan—Vomiting—Paclitaxel—ovarian cancer	0.00016	0.000642	CcSEcCtD
Olmesartan—Malaise—Epirubicin—ovarian cancer	0.000159	0.000638	CcSEcCtD
Olmesartan—Rash—Paclitaxel—ovarian cancer	0.000159	0.000636	CcSEcCtD
Olmesartan—Dermatitis—Paclitaxel—ovarian cancer	0.000158	0.000636	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—ovarian cancer	0.000158	0.000635	CcSEcCtD
Olmesartan—Syncope—Epirubicin—ovarian cancer	0.000158	0.000634	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—ovarian cancer	0.000158	0.000633	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—ovarian cancer	0.000158	0.000633	CcSEcCtD
Olmesartan—Headache—Paclitaxel—ovarian cancer	0.000158	0.000632	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—ovarian cancer	0.000157	0.000629	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—ovarian cancer	0.000156	0.000625	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—ovarian cancer	0.000155	0.000621	CcSEcCtD
Olmesartan—Cough—Epirubicin—ovarian cancer	0.000154	0.000617	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—ovarian cancer	0.000154	0.000616	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—ovarian cancer	0.000153	0.000614	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000151	0.000607	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—ovarian cancer	0.000151	0.000605	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—ovarian cancer	0.000151	0.000605	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—ovarian cancer	0.00015	0.000602	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—ovarian cancer	0.00015	0.000601	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—ovarian cancer	0.000149	0.0006	CcSEcCtD
Olmesartan—Nausea—Paclitaxel—ovarian cancer	0.000149	0.000599	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000149	0.000598	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—ovarian cancer	0.000148	0.000595	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—ovarian cancer	0.000147	0.00059	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—ovarian cancer	0.000146	0.000588	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—ovarian cancer	0.000146	0.000587	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—ovarian cancer	0.000146	0.000586	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—ovarian cancer	0.000146	0.000585	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—ovarian cancer	0.000144	0.000578	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—ovarian cancer	0.000144	0.000577	CcSEcCtD
Olmesartan—Oedema—Epirubicin—ovarian cancer	0.000144	0.000577	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—ovarian cancer	0.000143	0.000575	CcSEcCtD
Olmesartan—Infection—Epirubicin—ovarian cancer	0.000143	0.000573	CcSEcCtD
Olmesartan—Cough—Doxorubicin—ovarian cancer	0.000142	0.000571	CcSEcCtD
Olmesartan—Shock—Epirubicin—ovarian cancer	0.000141	0.000568	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—ovarian cancer	0.000141	0.000566	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—ovarian cancer	0.000141	0.000566	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—ovarian cancer	0.000141	0.000565	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—ovarian cancer	0.00014	0.000563	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—ovarian cancer	0.00014	0.00056	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—ovarian cancer	0.000139	0.000558	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—ovarian cancer	0.000139	0.000557	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—ovarian cancer	0.000139	0.000557	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—ovarian cancer	0.000139	0.000557	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—ovarian cancer	0.000138	0.000555	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000138	0.000553	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—ovarian cancer	0.000137	0.00055	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—ovarian cancer	0.000137	0.00055	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—ovarian cancer	0.000136	0.000544	CcSEcCtD
Olmesartan—Rash—Docetaxel—ovarian cancer	0.000134	0.000539	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—ovarian cancer	0.000134	0.000539	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—ovarian cancer	0.000134	0.000539	CcSEcCtD
Olmesartan—Headache—Docetaxel—ovarian cancer	0.000134	0.000536	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000133	0.000534	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—ovarian cancer	0.000133	0.000534	CcSEcCtD
Olmesartan—Infection—Doxorubicin—ovarian cancer	0.000132	0.00053	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000131	0.000526	CcSEcCtD
Olmesartan—Shock—Doxorubicin—ovarian cancer	0.000131	0.000525	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—ovarian cancer	0.00013	0.000524	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—ovarian cancer	0.00013	0.000523	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—ovarian cancer	0.00013	0.000522	CcSEcCtD
Olmesartan—AGTR1—female reproductive system—ovarian cancer	0.00013	0.0761	CbGeAlD
Olmesartan—Tachycardia—Doxorubicin—ovarian cancer	0.00013	0.000521	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—ovarian cancer	0.000129	0.000519	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000129	0.000516	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—ovarian cancer	0.000127	0.000509	CcSEcCtD
Olmesartan—Nausea—Docetaxel—ovarian cancer	0.000127	0.000508	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—ovarian cancer	0.000127	0.000508	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—ovarian cancer	0.000125	0.000502	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—ovarian cancer	0.000124	0.000499	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000124	0.000498	CcSEcCtD
Olmesartan—SLCO1B1—female reproductive system—ovarian cancer	0.000124	0.0726	CbGeAlD
Olmesartan—Fatigue—Epirubicin—ovarian cancer	0.000124	0.000497	CcSEcCtD
Olmesartan—Constipation—Epirubicin—ovarian cancer	0.000123	0.000493	CcSEcCtD
Olmesartan—Pain—Epirubicin—ovarian cancer	0.000123	0.000493	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000121	0.000486	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—ovarian cancer	0.00012	0.000483	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—ovarian cancer	0.000118	0.000475	CcSEcCtD
Olmesartan—AGTR1—vagina—ovarian cancer	0.000118	0.0688	CbGeAlD
Olmesartan—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000118	0.000472	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—ovarian cancer	0.000117	0.00047	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—ovarian cancer	0.000116	0.000464	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000115	0.000461	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—ovarian cancer	0.000115	0.00046	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—ovarian cancer	0.000114	0.000458	CcSEcCtD
Olmesartan—Pain—Doxorubicin—ovarian cancer	0.000114	0.000457	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—ovarian cancer	0.000114	0.000457	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—ovarian cancer	0.000114	0.000456	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—ovarian cancer	0.000114	0.000456	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—ovarian cancer	0.00011	0.00044	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000109	0.000437	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—ovarian cancer	0.000106	0.000424	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—ovarian cancer	0.000105	0.000422	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—ovarian cancer	0.000105	0.000422	CcSEcCtD
Olmesartan—AGTR1—testis—ovarian cancer	0.000105	0.0614	CbGeAlD
Olmesartan—Asthenia—Epirubicin—ovarian cancer	0.000103	0.000414	CcSEcCtD
Olmesartan—Pruritus—Epirubicin—ovarian cancer	0.000102	0.000408	CcSEcCtD
Olmesartan—Diarrhoea—Epirubicin—ovarian cancer	9.84e-05	0.000395	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—ovarian cancer	9.55e-05	0.000383	CcSEcCtD
Olmesartan—Dizziness—Epirubicin—ovarian cancer	9.51e-05	0.000382	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—ovarian cancer	9.41e-05	0.000378	CcSEcCtD
Olmesartan—ABCC2—female reproductive system—ovarian cancer	9.4e-05	0.055	CbGeAlD
Olmesartan—Vomiting—Epirubicin—ovarian cancer	9.14e-05	0.000367	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—ovarian cancer	9.1e-05	0.000365	CcSEcCtD
Olmesartan—Rash—Epirubicin—ovarian cancer	9.07e-05	0.000364	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—ovarian cancer	9.06e-05	0.000363	CcSEcCtD
Olmesartan—Headache—Epirubicin—ovarian cancer	9.01e-05	0.000361	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—ovarian cancer	8.8e-05	0.000353	CcSEcCtD
Olmesartan—Nausea—Epirubicin—ovarian cancer	8.54e-05	0.000343	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—ovarian cancer	8.46e-05	0.000339	CcSEcCtD
Olmesartan—Rash—Doxorubicin—ovarian cancer	8.39e-05	0.000337	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—ovarian cancer	8.38e-05	0.000336	CcSEcCtD
Olmesartan—Headache—Doxorubicin—ovarian cancer	8.34e-05	0.000334	CcSEcCtD
Olmesartan—Nausea—Doxorubicin—ovarian cancer	7.9e-05	0.000317	CcSEcCtD
Olmesartan—AGTR1—lymph node—ovarian cancer	7.61e-05	0.0445	CbGeAlD
Olmesartan—ABCC2—testis—ovarian cancer	7.59e-05	0.0444	CbGeAlD
Olmesartan—ABCC2—lymph node—ovarian cancer	5.5e-05	0.0322	CbGeAlD
